Literature DB >> 25517546

Replication of influenza A virus in swine umbilical cord epithelial stem-like cells.

Mahesh Khatri1, Kuldeep S Chattha.   

Abstract

In this study, we describe the isolation and characterization of epithelial stem-like cells from the swine umbilical cord and their susceptibility to influenza virus infection. Swine umbilical cord epithelial stem cells (SUCECs) expressed stem cell and pluripotency associated markers such as SSEA-1, SSEA-4, TRA 1-60 and TRA 1-81 and Oct4. Morphologically, cells displayed polygonal morphology and were found to express epithelial markers; pancytokeratin, cytokeratin-18 and occludin; mesenchymal cell markers CD44, CD90 and haematopoietic cell marker CD45 were not detected on these cells. The cells had extensive proliferation and self- renewal properties. The cells also possessed immunomodulatory activity and inhibited the proliferation of T cells. Also, higher levels of anti-inflammatory cytokine IL-10 were detected in SUCEC-T cell co-cultures. The cells were multipotent and differentiated into lung epithelial cells when cultured in epithelial differentiation media. We also examined if SUCECs are susceptible to infection with influenza virus. SUCECs expressed sialic acid receptors, used by influenza virus for binding to cells. The 2009 pandemic influenza virus and swine influenza virus replicated in these cells. SUCECs due to their differentiation and immunoregulatory properties will be useful as cellular therapy in a pig model for human diseases. Additionally, our data indicate that influenza virus can infect SUCECs and may transmit influenza virus from mother to fetus through umbilical cord and transplantation of influenza virus-infected stem cells may transmit infection to recipients. Therefore, we propose that umbilical cord cells, in addition to other agents, should also be tested for influenza virus before cryopreservation for future use as a cell therapy for disease conditions.

Entities:  

Keywords:  influenza virus; influenza virus transmission; stem cell transplantation; umbilical cord stem cells

Mesh:

Substances:

Year:  2015        PMID: 25517546      PMCID: PMC4603428          DOI: 10.4161/21505594.2014.983020

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  56 in total

Review 1.  Stem cells and aging: expanding the possibilities.

Authors:  M S Rao; M P Mattson
Journal:  Mech Ageing Dev       Date:  2001-05-31       Impact factor: 5.432

2.  Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord.

Authors:  Yuri A Romanov; Veronika A Svintsitskaya; Vladimir N Smirnov
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

3.  Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin.

Authors:  K Tobita; A Sugiura; C Enomote; M Furuyama
Journal:  Med Microbiol Immunol       Date:  1975-12-30       Impact factor: 3.402

4.  Organotypic culture and surface plantation using umbilical cord epithelial cells: morphogenesis and expression of differentiation markers mimicking cutaneous epidermis.

Authors:  Masayuki Mizoguchi; Yasushi Suga; Borisut Sanmano; Shigaku Ikeda; Hideoki Ogawa
Journal:  J Dermatol Sci       Date:  2004-09       Impact factor: 4.563

5.  Transplacental transmission and neonatal infection with swine influenza virus (Hsw1N1) in swine.

Authors:  G D Wallace; J L Elm
Journal:  Am J Vet Res       Date:  1979-08       Impact factor: 1.156

6.  Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects.

Authors:  Jay G Shake; Peter J Gruber; William A Baumgartner; Guylaine Senechal; Jennifer Meyers; J Mark Redmond; Mark F Pittenger; Bradley J Martin
Journal:  Ann Thorac Surg       Date:  2002-06       Impact factor: 4.330

7.  Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course.

Authors:  M C Shuhart; D Myerson; B H Childs; J D Fingeroth; J J Perry; D S Snyder; C L Spurgeon; C A Bevan; G B McDonald
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

8.  Human haematopoietic stem cells that mediate long-term in vivo engraftment are not susceptible to infection by human cytomegalovirus.

Authors:  Kirsten B Crapnell; Graca Almeida-Porada; Svetlana Khaiboullina; Steve C St Jeor; Esmail D Zanjani
Journal:  Br J Haematol       Date:  2004-03       Impact factor: 6.998

9.  The risk of infection transmission from blood progenitor cell concentrates.

Authors:  Milan Blaha; Pavel Mericka; Pavel Zak; Vlasta Stepanova; Lubos Vavra; Jaroslav Maly; Karla Tousovska
Journal:  J Hematother Stem Cell Res       Date:  2003-04

Review 10.  Emerging infections and pregnancy.

Authors:  Denise J Jamieson; Regan N Theiler; Sonja A Rasmussen
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

View more
  3 in total

1.  Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein.

Authors:  Ana Chumbe; Ray Izquierdo-Lara; Katherine Calderón; Manolo Fernández-Díaz; Vikram N Vakharia
Journal:  Virol J       Date:  2017-11-23       Impact factor: 4.099

2.  Influenza a virus-triggered autophagy decreases the pluripotency of human-induced pluripotent stem cells.

Authors:  Ali Zahedi-Amiri; Glen L Sequiera; Sanjiv Dhingra; Kevin M Coombs
Journal:  Cell Death Dis       Date:  2019-04-18       Impact factor: 8.469

3.  Quantitative Analysis of SSEA3+ Cells from Human Umbilical Cord after Magnetic Sorting.

Authors:  Zikuan Leng; Dongming Sun; Zihao Huang; Iman Tadmori; Ning Chiang; Nikhit Kethidi; Ahmed Sabra; Yoshihiro Kushida; Yu-Show Fu; Mari Dezawa; Xijing He; Wise Young
Journal:  Cell Transplant       Date:  2019-04-18       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.